R W Baldwin
- Immunology top 0.5%
- Molecular Biology top 5%
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Oncology top 2%
- Biotechnology top 0.5%
- Co-authors
- M. V. PimmM. J. EmbletonR. A. RobinsMichael R. PriceVera S. ByersC. R. BarkerD GlavesAlan C. Perkins
- Topics
- Monoclonal and Polyclonal Antibodies Research (105 papers)Immunotherapy and Immune Responses (52 papers)Glycosylation and Glycoproteins Research (45 papers)
- Partner nations
- United KingdomUnited StatesHungary
In The Last Decade
R W Baldwin
247 papers receiving 5.1k citations
Peers
Comparison fields: 5 of 148
- Immunology 2.8k
- Molecular Biology 2.2k
- Radiology, Nuclear Medicine and Imaging 2.1k
- Oncology 1.5k
- Biotechnology 680
Countries citing papers authored by R W Baldwin
This map shows the geographic impact of R W Baldwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R W Baldwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R W Baldwin more than expected).
Fields of papers citing papers by R W Baldwin
This network shows the impact of papers produced by R W Baldwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R W Baldwin. The network helps show where R W Baldwin may publish in the future.
Co-authorship network of co-authors of R W Baldwin
This figure shows the co-authorship network connecting the top 25 collaborators of R W Baldwin. A scholar is included among the top collaborators of R W Baldwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R W Baldwin. R W Baldwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 73 | |
| 2 | 22 | |
| 3 | 11 | |
| 4 | 6 | |
| 5 | 10 | |
| 6 | 12 | |
| 7 | 31 | |
| 8 | 18 | |
| 9 | Monoclonal antibody 791t 36 ricin a chain immunotoxin in the treatment of colorectal cancer | 1 |
| 10 | Monoclonal antibody drug targeting | 8 |
| 11 | 5 | |
| 12 | 15 | |
| 13 | 10 | |
| 14 | 26 | |
| 15 | 62 | |
| 16 | 4 | |
| 17 | Comparative studies of the metastatic potential of three transplantable rat mammary carcinomas of spontaneous origin. | 5 |
| 18 | 167 | |
| 19 | 2 | |
| 20 | 24 |
About R W Baldwin
R W Baldwin is a scholar working on Immunology, Biotechnology and Radiology, Nuclear Medicine and Imaging, having authored 256 papers that have together received 5.9k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (105 papers), Immunotherapy and Immune Responses (52 papers) and Glycosylation and Glycoproteins Research (45 papers). The work is most often cited by research in Immunology (2.8k citations), Radiology, Nuclear Medicine and Imaging (2.1k citations) and Biotechnology (680 citations). R W Baldwin has collaborated with scholars based in United Kingdom, United States and Hungary. Frequent co-authors include M. V. Pimm, M. J. Embleton, R. A. Robins, Michael R. Price, Vera S. Byers, C. R. Barker, D Glaves, Alan C. Perkins, B. M. Vose and J D Hardcastle. Their work appears in journals such as Nature, The Lancet and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.